141 related articles for article (PubMed ID: 34396656)
1. How to do hyperthermic intrathoracic chemotherapy for thoracic pseudomyxoma peritonei.
J Sharma V; Bhana J; Lolohea S; Meikle F
ANZ J Surg; 2022 Apr; 92(4):868-869. PubMed ID: 34396656
[No Abstract] [Full Text] [Related]
2. Cytoreductive surgery and concomitant hyperthermic thoracoabdominal chemotherapy for pseudomyxoma peritonei with abdominal and pleural involvement.
Fernando D; Larach JT; Flood MP; Warrier SK; McCormick JJ; Heriot AG; Waters PS
ANZ J Surg; 2022 Nov; 92(11):3072-3074. PubMed ID: 35170171
[No Abstract] [Full Text] [Related]
3. Pleural decortication and hyperthermic intrathoracic chemotherapy for pseudomyxoma.
Proesmans V; Vandaele T; Van Slambrouck J; Wolthuis A; D Hoore A; Dekervel J; Van Cutsem E; Dresen R; De Hertogh G; Degezelle K; Van Raemdonck D; Nafteux P; Ceulemans LJ
Int J Hyperthermia; 2022; 39(1):1153-1157. PubMed ID: 36049823
[No Abstract] [Full Text] [Related]
4. Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery.
Scally CP; Fournier KF; Mansfield PF
JAMA Surg; 2021 Mar; 156(3):e206364. PubMed ID: 33502464
[No Abstract] [Full Text] [Related]
5. Cytoreductive Surgery and Hyperthermic Chemotherapy for Intrathoracic Pseudomyxoma Peritonei.
Kawaguchi Y; Hanaoka J
Ann Thorac Surg; 2020 Dec; 110(6):e541-e543. PubMed ID: 32553770
[TBL] [Abstract][Full Text] [Related]
6. Clinical findings of patients with pseudomyxoma peritonei of appendiceal origin undergoing Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Iavazzo C; Spiliotis J
Updates Surg; 2020 Sep; 72(3):923-924. PubMed ID: 32602012
[No Abstract] [Full Text] [Related]
7. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for a limited low-grade pseudomyxoma peritonei-a video vignette.
Arjona-Sánchez Á; Durán M; Rodríguez-Ortiz L; Rufián-Peña S; Briceño J
Colorectal Dis; 2021 Jan; 23(1):331-332. PubMed ID: 33070418
[No Abstract] [Full Text] [Related]
8. Is a Prognostic Nomogram for Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Useful?
Levine EA
JAMA Surg; 2023 May; 158(5):531. PubMed ID: 36920379
[No Abstract] [Full Text] [Related]
9. Haemodynamic changes during hyperthermic intra-thoracic chemotherapy for pseudomyxoma peritonei.
Ashraf-Kashani N; Bell J
Int J Hyperthermia; 2017 Sep; 33(6):675-678. PubMed ID: 28540781
[TBL] [Abstract][Full Text] [Related]
10. Clinical results of cytoreduction and HIPEC in pseudomyxoma peritonei.
Lutton NJ; Moran BJ
Cancer Treat Res; 2007; 134():319-28. PubMed ID: 17633063
[No Abstract] [Full Text] [Related]
11. [Pseudomyxoma peritonei; a rare tumour that can be treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Smeenk RM; Verwaal VJ; Zoetmulder FA
Ned Tijdschr Geneeskd; 2007 Feb; 151(7):418-23. PubMed ID: 17343142
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative hyperthermic intrathoracic chemotherapy for pleural extension of pseudomyxoma peritonei.
Dang A; Mansfield P; Ilsin B; Hightower C; Aravindan N; Rice D; Riedel B
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):265-8. PubMed ID: 17418746
[No Abstract] [Full Text] [Related]
13. [Treatment of pseudomyxoma peritonei using cytoreduction and intraperitoneal hyperthermic chemotherapy].
Scuderi S; Costamagna D; Vaira M; Barone R; De Simone M
Tumori; 2003; 89(4 Suppl):43-5. PubMed ID: 12903542
[TBL] [Abstract][Full Text] [Related]
14. [Cytoreductive surgery (peritonectomy) and intraperitoneal hyperthermic chemotherapy: an innovative and effective approach to the treatment of pseudomyxoma peritonei].
Deraco M; Kusamura S; Gronchi A
Tumori; 2003; 89(4 Suppl):54-5. PubMed ID: 12903545
[TBL] [Abstract][Full Text] [Related]
15. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
[TBL] [Abstract][Full Text] [Related]
16. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
[TBL] [Abstract][Full Text] [Related]
17. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei.
Witkamp AJ; de Bree E; Kaag MM; van Slooten GW; van Coevorden F; Zoetmulder FA
Br J Surg; 2001 Mar; 88(3):458-63. PubMed ID: 11260116
[TBL] [Abstract][Full Text] [Related]
18. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei (Br J Surg 2001; 88: 458-63).
Jähne J
Br J Surg; 2001 Aug; 88(8):1130. PubMed ID: 11488802
[No Abstract] [Full Text] [Related]
19. Commentary on 'Survival of patients with pseudomyxoma peritonei treated by serial debulking'.
Moran BJ
Colorectal Dis; 2010 Sep; 12(9):872-3. PubMed ID: 20718839
[No Abstract] [Full Text] [Related]
20. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report.
Thorgersen EB; Melum E; Folseraas T; Larsen SG; Line PD
World J Surg Oncol; 2018 Sep; 16(1):180. PubMed ID: 30185175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
